Budget 2026: R&D Tax Is Being Rebuilt – Here’s What to Do Before 2028

Budget 2026: R&D Tax Is Being Rebuilt – Here’s What to Do Before 2028

The 2026 Budget delivers the biggest R&D Tax Incentive restructure since 2020. Some startups will be better off. Some won’t. Here’s what’s changing and what to do before July 2028.

Jump to...

Facebook
Tweet
LinkedIn
The 2026 Budget delivers the biggest R&D Tax Incentive restructure since 2020. Some startups will be better off. Some won’t. Here’s what’s changing and what to do before July 2028.

Update, September 2026. Treasury released the exposure draft for these reforms on 11 September 2026. The changes below are confirmed, and the draft adds the detail founders most needed on the 10-year refundability limit: the clock starts from when your company began trading, not from your first R&D claim, and a new company can’t reset it. We work through how to find your own cutoff year in our update on the exposure draft.

The 2026-27 Federal Budget delivered the most significant restructure of the R&D Tax Incentive (RDTI) since 2020. Some startups will be materially better off. Some may be materially worse off. And almost none of the changes hit until 1 July 2028, which means you have a planning window, not a panic.

Here is what we think actually matters.

The seven RDTI changes, in plain English

From 1 July 2028, the RDTI looks structurally different. The headline pieces:

  1. The minimum claim threshold lifts from $20,000 to $50,000. Small claims below $50k will only stay eligible if the work is done through a registered Research Service Provider or Cooperative Research Centre.
  2. The core R&D offset rate increases by ~4.5 percentage points. For eligible companies that translates to roughly 48% rebate on core experimental R&D, up from 43.5%.
  3. Supporting R&D activities lose eligibility. This is the change everyone is underestimating, and it can be a material part of many claims. As an example, for software, hardware, biotech, medtech, advanced manufacturing and anyone running trials, integration work or process development around their core IP, this can be a material cut to your claimable base.
  4. Refundability is now restricted to companies under 10 years old. The exposure draft confirms that 10 years runs from when your company started trading, not from your first R&D claim. If you are past it and still loss-making, you keep the higher offset rate but you cannot get cash back. You carry losses forward instead.
  5. Refundable offset turnover threshold lifts from $20m to $50m. More growing companies stay on the refundable side of the regime for longer. This is the single biggest cash-flow positive in the package for scaling startups.
  6. The intensity threshold for companies above $50m turnover drops from 2% to 1.5%. This makes it easier for larger firms doing meaningful R&D to access the higher rate.
  7. The expenditure cap lifts from $150m to $200m. Useful for a very small number of very large R&D spenders. Most of you can ignore this one.

Two timing notes. The reforms apply from 1 July 2028, which means FY29 onwards. Income years ending 30 June 2027 and 30 June 2028 will run under existing rules, but with heightened integrity and anti-fraud scrutiny on claims. Make sure your documentation is in order – the ATO and AusIndustry will be looking harder during the transition.

What this means for founders right now

You have roughly 25 months until the new rules apply. Here is how we would use that time.

1. Audit your supporting R&D exposure

Pull your last two RDTI claims. What percentage of total eligible expenditure sat in supporting activities versus core experimental activities? That ratio tells you exactly how exposed you are to the eligibility change. If supporting activities are above 30% of your claim, you have real work to do on how you scope and document R&D going forward.

2. Reframe what counts as core

In a lot of cases, what may have historically been documented as supporting is actually core experimental work that has been described loosely. Tighter framing, better contemporaneous evidence and clearer hypothesis-experiment-result documentation can move expenditure into the core bucket where it belongs. Start this now, not in FY29.

3. Stack the new loss refundability measure with R&D

From 1 July 2028, loss-making companies under $10m turnover in their first two years can convert losses into a refundable offset, capped at FBT and PAYG withholding on Australian wages. Combined with R&D refundability at 48%, the stack delivers materially more cash per loss year than R&D alone – with the government effectively co-funding more than half of a typical early-stage loss year. We have written a separate piece on how loss carry-back and loss refundability work in practice with a worked example of the R&D + loss refundability stack.

The bigger picture

The government’s stated logic is “better targeting and simplifying” the program toward high-impact innovation. The honest read is that they’re taking dollars out of supporting activities, recycling some into a higher core rate, and using the savings to fund the loss carry-back scheme and the permanent instant asset write-off.

This is general information, not advice. The rules above are technical and the right move depends on your specific situation.

Book a call with Standard Ledger to talk through what these changes mean for your startup.

Facebook
Tweet
LinkedIn
Remco Marcelis

Written by

Remco Marcelis

Co-founder & CEO, Standard Ledger

Remco Marcelis is co-founder and CEO of Standard Ledger, the accounting and CFO firm built specifically for startups and scale-ups. He has worked with startups and fast-growing SMEs as a CFO and virtual CFO for around 15 years, following four years as a venture capital fund investment manager and ten years in multinational consulting.

He is a chartered accountant with an advanced MBA from the University of Adelaide and a graduate of the Australian Institute of Company Directors. He writes here on fractional CFO work, financial modelling, capital raising and the financial decisions Australian founders face at each stage of growth.

FAQ

Questions founders ask us.

These are the things founders most often want to know before working with us. If your question isn't here, bring it along when you speak with us.

The 2026 Federal Budget announced the most significant restructure of Australia’s R&D Tax Incentive (RDTI) since 2020, taking effect from 1 July 2028. The minimum claim threshold rises from $20,000 to $50,000, the core offset rate increases to roughly 48% from 43.5%, supporting R&D activities lose eligibility entirely, and refundability is restricted to companies under 10 years old, measured from when the company started trading rather than from its first R&D claim. The refundable offset turnover threshold also lifts from $20m to $50m, which is a positive for scaling startups.

From 1 July 2028, supporting R&D activities will no longer be eligible under Australia’s R&D Tax Incentive. This is significant for companies in software, hardware, biotech, medtech and advanced manufacturing, where supporting activities – such as trials, integration work and process development – can make up a material portion of total R&D claims. Founders should audit their last two RDTI claims now to understand how exposed they are before the new rules apply.

The R&D Tax Incentive changes announced in the 2026 Federal Budget take effect from 1 July 2028, applying to FY29 onwards. Income years ending 30 June 2027 and 30 June 2028 still run under existing rules. However, the ATO and AusIndustry have flagged heightened scrutiny of claims during the transition period, so documentation standards matter now even before the new regime begins.

Startups that do a high proportion of core experimental R&D and have turnover between $20m and $50m stand to benefit most. The core offset rate rising to roughly 48% increases the cash value of eligible claims, and the refundable offset threshold lifting from $20m to $50m means more scaling companies can access cash refunds rather than carrying offsets forward. Early-stage startups in their first two years can also stack R&D refundability with the new loss refundability measure from 1 July 2028.

There are roughly 25 months before the new rules apply, and there are three things worth doing now. First, get help to review your R&D claims and audit your last two RDTI claims to understand what proportion of your eligible expenditure sits in supporting versus core activities. Second, review how your R&D is documented – work that has been loosely described as supporting may qualify as core experimental activity with tighter framing and better contemporaneous evidence. Third, if you’re in your first two years of operation from July 2028, plan to stack the new loss refundability measure with your R&D offset to maximise cash recovery.

Events coming up

[wfea layout="event" order_by="asc" newtab="true" organization_id="136577770604" status="live" readmore="false" thumb_original="true" venue_name="true" booknow_text="Book now" limit="2" no_events_found_text="We're not running any events at the moment."]

Join Our Free Startup Events

Empower Your Startup with Financial Knowledge

Looking to sharpen your financial skills or learn how to secure funding for your startup? Our in-person and online events are designed to empower founders like you with practical knowledge on topics like equity, valuations, tax incentives, and scaling strategies. Whether you’re preparing for an investor pitch or navigating complex financial models, we’ve got you covered.

Startup Tips & Insights: Take a Read

Without a board, nobody checks a self-funded founder's numbers. Here's when a bootstrapped business genuinely needs CFO support, the signals to watch for, and what the work looks like when you aren't raising.
A smaller business you own outright can leave you with more than a bigger one you own 42% of. Here's how to work out how large the funded path needs to get - preferences included - before it pays off.
Before you pick a number for your employee share scheme, you need to know whether you qualify for the startup tax concession. Here’s how the concession, the valuation methods and the timing fit together.
Buying the shares or buying the assets is one of the highest-value decisions in any acquisition. It shapes your tax bill, the liabilities you inherit and even the price. Here’s how the two structures compare.